Augmentation versus inhibition: Effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor

J. Kjaergaard, L. Peng, P. A. Cohen, J. A. Drazba, A. D. Weinberg, S. Shu

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'Augmentation versus inhibition: Effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor'. Together they form a unique fingerprint.

Medicine & Life Sciences